Indivior Pharmaceuticals, Inc. (INDV)
38.62
+1.23
(+3.29%)
USD |
NASDAQ |
Jun 09, 15:29
Indivior Pharmaceuticals SG&A Expense (Quarterly) : 124.00M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 73.66M |
| Liquidia Corp. | 46.94M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Theravance Biopharma, Inc. | 20.17M |
| Viatris, Inc. | 928.80M |